518 related articles for article (PubMed ID: 17252206)
1. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
2. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.
Paolino D; Cosco D; Muzzalupo R; Trapasso E; Picci N; Fresta M
Int J Pharm; 2008 Apr; 353(1-2):233-42. PubMed ID: 18191509
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models.
Marianecci C; Rinaldi F; Mastriota M; Pieretti S; Trapasso E; Paolino D; Carafa M
J Control Release; 2012 Nov; 164(1):17-25. PubMed ID: 23041542
[TBL] [Abstract][Full Text] [Related]
4. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
[TBL] [Abstract][Full Text] [Related]
5. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil.
Cosco D; Paolino D; Muzzalupo R; Celia C; Citraro R; Caponio D; Picci N; Fresta M
Biomed Microdevices; 2009 Oct; 11(5):1115-25. PubMed ID: 19507033
[TBL] [Abstract][Full Text] [Related]
6. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
9. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
11. A new crown ether as vesicular carrier for 5-fluoruracil: synthesis, characterization and drug delivery evaluation.
Muzzalupo R; Nicoletta FP; Trombino S; Cassano R; Iemma F; Picci N
Colloids Surf B Biointerfaces; 2007 Aug; 58(2):197-202. PubMed ID: 17434295
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of bolaform surfactant vesicles.
Muzzalupo R; Trombino S; Iemma F; Puoci F; La Mesa C; Picci N
Colloids Surf B Biointerfaces; 2005 Dec; 46(2):78-83. PubMed ID: 16257519
[TBL] [Abstract][Full Text] [Related]
15. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.
Gupta M; Vaidya B; Mishra N; Vyas SP
Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195
[TBL] [Abstract][Full Text] [Related]
16. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery.
Barone A; Cristiano MC; Cilurzo F; Locatelli M; Iannotta D; Di Marzio L; Celia C; Paolino D
Colloids Surf B Biointerfaces; 2020 Sep; 193():111152. PubMed ID: 32535351
[TBL] [Abstract][Full Text] [Related]
17. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
[TBL] [Abstract][Full Text] [Related]
18. Liposomes and niosomes as topical drug delivery systems.
Choi MJ; Maibach HI
Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
[TBL] [Abstract][Full Text] [Related]
19. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125
[TBL] [Abstract][Full Text] [Related]
20. Preparation of curcuminoid niosomes for enhancement of skin permeation.
Rungphanichkul N; Nimmannit U; Muangsiri W; Rojsitthisak P
Pharmazie; 2011 Aug; 66(8):570-5. PubMed ID: 21901978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
